Side effect guides
Nausea on GLP-1: Log Triggers in Pokii
Nausea is the single most commonly reported side effect across GLP-1 clinical trial programs, and if you're feeling it after a dose or a meal, you're far from alone. It's also rarely random — for most people it tracks with dose changes and with what, how much, and how fast they ate. This guide covers why GLP-1 nausea happens, approaches that are commonly discussed for managing it, when it's time to call your prescriber, and how logging meals, water, and symptom severity in Pokii can help you see your own patterns clearly enough to talk them through with your care team.
Why nausea happens on GLP-1s, and how it typically shows up
GLP-1 receptor agonists, and dual GLP-1/GIP medications like tirzepatide, work in part by slowing gastric emptying — food stays in the stomach longer, which is part of what produces the fullness these medications are designed to create. That same slowdown is also a major reason nausea and a sense of heaviness after eating are so common. There's a second mechanism at work too: these medications act directly on GLP-1 receptors in brain regions, including areas involved in regulating nausea and vomiting, independent of anything happening in the stomach. Because of both mechanisms, nausea is listed as a common adverse reaction on the FDA-approved label for semaglutide (Wegovy), and it's described by the manufacturer as one of the most frequently reported side effects across the GLP-1 drug class.
Reported rates vary by specific drug and dose, but nausea is commonly cited in the range of roughly 40 to 56 percent of patients across semaglutide and tirzepatide trials. It most often appears or worsens after starting a medication and again after each dose increase, typically peaking within the first one to few weeks of a new dose before easing as the body adjusts. Commonly reported triggers include large meals, high-fat or greasy foods, eating too quickly, and lying down soon after eating — all consistent with the delayed-gastric-emptying mechanism described above. Recognizing that pattern, and that a new titration step tends to bring a temporary uptick, can make the first rough week after a dose increase feel less alarming and easier to plan around.
Commonly discussed approaches — general information, not instructions
The following are approaches that patients and clinicians commonly discuss when it comes to managing GLP-1-related nausea. They're offered here as general information, not as personal medical advice, and they aren't a substitute for guidance from a prescriber who knows your health history. What works varies by person, and none of it should be read as a set of instructions to follow.
Many clinicians and patients report that eating smaller, more frequent meals — rather than a few large ones — is easier to tolerate, and choosing lower-fat, less greasy meals is frequently recommended for the same reason, since high-fat foods can be harder to handle when gastric emptying is already slowed. Eating slowly and stopping at the first sign of fullness is commonly suggested as a way to avoid overfilling the stomach, and staying upright for a while after eating, rather than lying down right away, is another commonly discussed approach, since lying down soon after a meal may slow digestion further.
Hydration comes up frequently too. Steady sipping of fluids throughout the day, rather than large amounts all at once, is commonly mentioned as more comfortable for some people, alongside general guidance to stay well hydrated — hydration is emphasized specifically because GI side effects like nausea can raise the risk of dehydration. Ginger, whether as tea or candies, is also frequently mentioned in patient-facing nausea guidance as something some people find helpful, though it isn't an FDA-labeled treatment for GLP-1-related nausea and its effectiveness is based on anecdotal, self-reported experience rather than a specific proven mechanism. Anyone experiencing persistent or bothersome nausea should bring it up with their prescriber, who may adjust dose timing, titration pace, or the medication itself.
When to contact a prescriber
Some nausea signals warrant a call, not just a wait-and-see approach. Per manufacturer and FDA labeling for semaglutide (Wegovy/Ozempic), contact a health care provider promptly if you experience nausea, vomiting, or diarrhea that doesn't go away or that keeps you from keeping fluids down, or if you notice signs of dehydration — this is called out specifically because GI side effects can cause fluid loss that may lead to kidney problems.
Severe or persistent pain in the upper abdomen, especially if it radiates to the back, with or without nausea or vomiting, is highlighted by the manufacturer as a possible sign of pancreatitis; the guidance is to stop the medication and seek care right away if this happens. More broadly, any nausea or GI symptom that is severe, worsening, or unusual compared with your prior experience on the medication is worth flagging to your prescriber rather than waiting it out. This summarizes manufacturer and FDA guidance for general awareness — it isn't a substitute for your prescriber's individualized advice, and Pokii does not diagnose or triage symptoms.
What Pokii supports for tracking your own patterns
Pokii doesn't tell you what's causing your nausea or what to do about it — but it can help you see the pattern clearly enough to bring something concrete to your prescriber. The Daily check-in lets you log side effects with a severity rating and notes, and it shows relative-to-last hints so you can see at a glance whether nausea is trending up or down compared with your previous entry; the custom side effects list lets you make sure nausea specifically is included in your check-ins. Because side-effect entries tie to dose timing in the app's history, it becomes easier to notice whether nausea tends to spike after a dose or a dose increase, matching the peak-then-ease pattern described above.
Meal timing and context are captured through Pokii's Nutrition dashboard, which pulls calories, protein, carbs, fat, fiber, sugar, and sodium from Apple Health, including data written by Pokii's own AI photo meal scanning in Pokii. That makes it possible to line up what and when you ate against a nausea entry logged later the same day — useful if you suspect a connection to meal size, fat content, or timing. Water intake is tracked with the glass-based Water tracker, free on every tier, with Smart water reminders available in Pokii — relevant given how strongly hydration is emphasized in FDA guidance around GI side effects.
To see severity over time, the Dashboard's Today's log section unifies shots, check-ins, meals, and weight for a given day, and the Calendar's month and list views show the same information across a longer stretch, so you can visually connect a dose or dose increase to nausea severity in the days that follow. The projected medication levels chart — an educational model, not lab results — can be viewed alongside your logged side effects for additional context. If you want to bring all of this to an appointment, Pokii's configurable PDF progress reports can include side effects, appetite, mood, and notes together, giving your prescriber a compact view of your pattern rather than a verbal summary from memory. As with everything else in Pokii, this is a tracking and education tool — it does not provide medical advice, diagnosis, or treatment, and any pattern you spot is meant to start a conversation with your prescriber, not replace one.
Always follow your prescriber’s instructions for GLP-1 medications. Pokii helps you log and visualize your journey; it does not replace professional care.